Association Between Fractional Exhaled Nitric Oxide and Asthma Control

Completed

• Conditions: Bronchial Asthma

• Registration Number: NCT01197690
• Lead Sponsor: Mahidol University

Brief Summary

The purpose of this study is to determine mean or median of fractional exhaled nitric oxide (FeNO) in Thai atopic asthmatic patients that divided into subgroups due to level of asthma control according to the global initiative for asthma guideline.

Detailed Description

From many previous studies, fractional exhaled nitric oxide (FeNO) has many benefits such as non-invasive, easily to perform, less time consume, has direct association with severity of inflammation of bronchial trees and sputum eosinophils, has benefit for diagnosis and monitoring the treatment in asthmatic patients.

In Thailand, this field of study is less extend, especially in children population. We hypothesized that in uncontrolled or partly controlled group may have high level of fractional exhaled nitric oxide (FeNO) than controlled group.

It is therefore desirable to examine the association between fractional exhaled nitric oxide (FeNO) and level of asthma control among atopic asthmatic Thai children and will be the main objective of this research.

Study Timeline

• Study Start: 2010-02
• Study First Submitted: 2010-07-18
• Study First Submitted QC: 2010-09-07
• Study First Posted: 2010-09-09
• Primary Completion: 2010-12
• Study Completion: 2010-12
• Status Verified: 2015-09
• Last Update Submitted: 2015-09-17
• Last Update Posted: 2015-09-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

• clinical diagnosis of atopic bronchial asthma
• follow up in clinic of allergy and clinical immunology, Siriraj hospital

Exclusion Criteria

• smoker or past history of smoking
• has chronic disease eg. HIV infection, pulmonary hypertension, systemic lupus erythematosus, liver cirrhosis, gastroesophageal reflux, COPD, bronchiectasis
• drink ethanol within 48 hours before enrollment
• history of upper or lower respiratory tract infection within 6 weeks before enrollment
• drink caffeine within day before enrollment
• during pregnancy
• history of systemic steroid use within 8 weeks before enrollment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
fractional exhaled nitric oxide level	10 minutes (average time), on the day of enrollment

Secondary Outcome Measures

Name	Time	Method
scores of asthma control test: ACT	5 minutes (average time), on the day of enrollment

Trial Locations

Locations (1)

Siriraj Hospital; 🇹🇭 Bangkok, Thailand